Concepedia

Vít Šesták

VŠ

Statistics

Publications

6

Citations

131

H-Index

6

Active since

2012

Affiliations

Charles University(Current)

University of Hradec Králové

The University of Sydney

University of Defence

University Hospital Hradec Králové

Vít Šesták is an author at Charles University specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2012–2020

6

Publications

6

Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents

Vít Šesták, Ján Stariat, Jolana Cermanová et al. · Oncotarget · 2015 · 44 citations · Full text

Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite

Jan Bureš, Anna Jirkovská, Vít Šesták et al. · Toxicology · 2017 · 27 citations

, , +9

A UHPLC-UV-QTOF study on the stability of carfilzomib, a novel proteasome inhibitor

Vít Šesták, Jaroslav Roh, Libuse Klepalova et al. · Journal of Pharmaceutical and Biomedical Analysis · 2016 · 18 citations

, , +8

LC-MS/MS identification of the principal in vitro and in vivo phase I metabolites of the novel thiosemicarbazone anti-cancer drug, Bp4eT

Ján Stariat, Vít Šesták, Kateřina Vávrová et al. · Analytical and Bioanalytical Chemistry · 2012 · 17 citations

, , +7

Interaction of Cucurbit[7]uril with Oxime K027, Atropine, and Paraoxon: Risky or Advantageous Delivery System?

Jana Žďárová Karasová, Martin Mžik, Tomáš Kučera et al. · International Journal of Molecular Sciences · 2020 · 15 citations · Full text

1–5 of 6